Patents by Inventor Thomas Stranzl

Thomas Stranzl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKER METHODS FOR TREATMENT OF ATOPIC DISEASE BY IMMUNOTHERAPY
    Publication number: 20210214794
    Abstract: The invention provides methods related to the detection of specific biomarkers in combination with use of immunotherapy products for treatment of atopic disease. More specifically, biomarkers useful for selecting subjects for treating, preventing, or reducing risk of asthma by use of immunotherapy, e.g. allergen-specific immunotherapy. Further, the invention provides immunotherapy products for use in methods involving the detection of one or more biomarkers, as well as kits of parts for detection of biomarkers related to asthma.
    Type: Application
    Filed: May 22, 2019
    Publication date: July 15, 2021
    Applicant: ALD-ABELLÓ A/S
    Inventors: Ilka Hoof, Peter Sejer Andersen, Thomas Stranzl, Stephanie Bramd
  • IMMUNOGENIC PROTEINS AND FRAGMENTS THEREOF FROM ALLERGENIC MITES
    Publication number: 20200123213
    Abstract: The invention relates to novel immunogenic polypeptides identified in house dust mites and storage mites, which have the potential to be used in allergy immunotherapy, for diagnostic purposes, eventually via production of antibodies binding the polypeptide or for characterising allergen extracts of house dust mites and storage mites.
    Type: Application
    Filed: December 20, 2019
    Publication date: April 23, 2020
    Applicants: ALK-ABELLÓ A/S, LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
    Inventors: Bjoern Peters, Gitte Lund, Lars Harder Christensen, Thomas Stranzl, Alessandro Sette
  • Immunogenic proteins and fragments thereof from allergenic mites
    Patent number: 10556936
    Abstract: The invention relates to novel immunogenic polypeptides identified in house dust mites and storage mites, which have the potential to be used in allergy immunotherapy, for diagnostic purposes, eventually via production of antibodies binding the polypeptide or for characterising allergen extracts of house dust mites and storage mites.
    Type: Grant
    Filed: May 29, 2017
    Date of Patent: February 11, 2020
    Assignees: ALK ABELLÓ, LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
    Inventors: Bjoern Peters, Gitte Lund, Lars Harder Christensen, Thomas Stranzl, Alessandro Sette
  • IMMUNOGENIC PROTEINS AND FRAGMENTS THEREOF FROM ALLERGENIC MITES
    Publication number: 20190202875
    Abstract: The invention relates to novel immunogenic polypeptides identified in house dust mites and storage mites, which have the potential to be used in allergy immunotherapy, for diagnostic purposes, eventually via production of antibodies binding the polypeptide or for characterising allergen extracts of house dust mites and storage mites.
    Type: Application
    Filed: May 29, 2017
    Publication date: July 4, 2019
    Applicants: ALK-ABELLÓ A/S, LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
    Inventors: Bjoern Peters, Gitte Lund, Lars Harder Christensen, Thomas Stranzl, Alessandro Sette